» Articles » PMID: 21808130

ICMR-DBT Guidelines for Evaluation of Probiotics in Food

Overview
Specialty General Medicine
Date 2011 Aug 3
PMID 21808130
Citations 52
Affiliations
Soon will be listed here.
Abstract

There has been an increased influx of probiotic products in the Indian market during the last decade. However, there has been no systematic approach for evaluation of probiotics in food to ensure their safety and efficacy. An initiative was, therefore, taken by the Indian Council of Medical Research (ICMR) along with the Department of Biotechnology (DBT) to formulate guidelines for regulation of probiotic products in the country. These guidelines define a set of parameters required for a product/strain to be termed as 'probiotic'. These include identification of the strain, in vitro screening for probiotic characteristics, animal studies to establish safety and in vivo animal and human studies to establish efficacy. The guidelines also include requirements for labeling of the probiotic products with strain specification, viable numbers at the end of shelf life, storage conditions, etc., which would be helpful to the consumers to safeguard their own interest.

Citing Articles

Inhibition, Gastritis Attenuation, and Gut Microbiota Protection in C57BL/6 Mice by NCUH062003.

Li J, Xu X, Yang S, Liu K, Wu M, Xie M Microorganisms. 2025; 12(12.

PMID: 39770724 PMC: 11678540. DOI: 10.3390/microorganisms12122521.


In Vitro Screening of Bacterial Isolates From Dairy Products for Probiotic Properties and Other Health-Promoting Attributes.

Modasiya I, Mori P, Maniya H, Chauhan M, Grover C, Kumar V Food Sci Nutr. 2024; 12(12):10756-10769.

PMID: 39723103 PMC: 11666839. DOI: 10.1002/fsn3.4537.


Appraisal of postbiotics in cancer therapy.

Sudaarsan A, Ghosh A Front Pharmacol. 2024; 15:1436021.

PMID: 39372197 PMC: 11449718. DOI: 10.3389/fphar.2024.1436021.


Current insights on gut microbiome and chronic urticaria: progress in the pathogenesis and opportunities for novel therapeutic approaches.

Cai R, Zhou C, Tang R, Meng Y, Zeng J, Li Y Gut Microbes. 2024; 16(1):2382774.

PMID: 39078229 PMC: 11290762. DOI: 10.1080/19490976.2024.2382774.


Bidirectional communication of the gut-brain axis: new findings in Parkinson's disease and inflammatory bowel disease.

Wanyi Z, Jiao Y, Wen H, Bin X, Xuefei W, Lan J Front Neurol. 2024; 15:1407241.

PMID: 38854967 PMC: 11157024. DOI: 10.3389/fneur.2024.1407241.


References
1.
Reid G . The importance of guidelines in the development and application of probiotics. Curr Pharm Des. 2005; 11(1):11-6. DOI: 10.2174/1381612053382395. View

2.
Saldanha L . US Food and Drug Administration regulations governing label claims for food products, including probiotics. Clin Infect Dis. 2008; 46 Suppl 2:S119-21. DOI: 10.1086/523328. View

3.
von Wright A . Regulating the safety of probiotics--the European approach. Curr Pharm Des. 2005; 11(1):17-23. DOI: 10.2174/1381612053382322. View

4.
Przyrembel H . Consideration of possible legislation within existing regulatory frameworks. Am J Clin Nutr. 2001; 73(2 Suppl):471S-475S. DOI: 10.1093/ajcn/73.2.471s. View

5.
. Specifications for the identity and purity of food additives and their toxicological evaluation: some antimicrobials, antioxidants, emulsifiers, stabilizers, flour-treatment agents, acids, and bases; ninth report of the joint FAO-WHO expert.... World Health Organ Tech Rep Ser. 1966; 339:1-24. View